Purchase Order 75F40124P00205
Award Date
6/6/24
Potential Completion Date
6/18/27
Potential Value
$32K
Federal Agency
Food and Drug Administration
Awardee
Nexus Group, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract to Nexus Group, LLC, a small, minority-owned business, for the preventative maintenance and repair services of a 3730xL genetic analyzer used by the FDA's Center for Biologics Evaluation and Research (CBER). The contract, valued at $37,800.00, covers one scheduled preventive maintenance visit annually and unlimited on-site corrective maintenance over a 3-year period from June 27, 2025 to June 30, 2028....
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Nexus Group, LLC, a small, minority-owned, and self-certified small disadvantaged business, to provide corrective/remedial repair and preventive maintenance services for MISEQ instruments. The contract has a ceiling value of $54,000.00 and a period of performance through February 28, 2030. Nexus Group, LLC has extensive experience delivering technical services for laboratory, medical, and analytical...
The Department of Health and Human Services Food and Drug Administration awarded a $67,963.80 firm fixed price purchase order to Illumina, Inc. for corrective, remedial, repair, and preventive maintenance services for Illumina's MiSeq sequencing systems. The contract has a period of performance through February 28, 2025 and was awarded on December 12, 2019. No set-aside designation was used for this award to support the FDA's medical device evaluation programs through ongoing maintenance and...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Nexus Group, LLC, a small, minority-owned, and self-certified small disadvantaged business based in Charlotte, North Carolina. The contract, valued at $54,900.00, is for a MISEQ SILVER SUPPORT PLAN for serial number M04120. The contract has an ultimate completion date of July 13, 2030 and was awarded on July 9, 2025. Nexus Group, LLC is an SBA 8(a) Business Development Program participant...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for $170,153.16 to provide annual on-site preventative maintenance service and unlimited repairs as needed on two Illumina MiSeq whole genome sequencers for a base year plus four option years. The contract has no set-aside designation. Based on Illumina's history as a prime contractor and subcontractor for sequencing systems and services across various federal agencies, this award aligns...
The U.S. Food and Drug Administration (FDA) awarded Illumina, Inc. a firm fixed-price purchase order worth $425,145.40 for a 12-month preventative maintenance service agreement with four 12-month option periods. This award is in support of five MiSeq sequencing instruments for the FDA's Center for Food Safety and Applied Nutrition (CFSAN). As the original equipment manufacturer (OEM) and sole authorized provider of maintenance for the MiSeq instruments, Illumina was awarded this sole-source...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $21,183, is for the provision of preventative maintenance services for Illumina's MiSeq benchtop sequencer. The contract does not have a set-aside designation. Illumina has extensive experience providing sequencing systems, reagents, and maintenance services to a variety of...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the repair and maintenance of seven Illumina MiSeq instruments owned by the FDA's Center for Food Safety and Applied Nutrition (CFSAN). The contract includes a base period of performance through December 30, 2027, with four one-year option periods. The total ceiling value of the contract is $422,733.60. Illumina, a manufacturer of sequencing and genomic analysis instruments and...